HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I-J Jang Selected Research

YH4808

1/2017A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I-J Jang Research Topics

Disease

1Gastroesophageal Reflux (GERD)
01/2017
1Type 2 Diabetes Mellitus (MODY)
08/2014
1Critical Illness (Critically Ill)
12/2012
1Hyperlipidemias (Hyperlipidemia)
11/2011
1Hypertriglyceridemia
11/2011
1Hypercholesterolemia
11/2011
1Neoplasms (Cancer)
10/2011
1Thrombosis (Thrombus)
10/2011

Drug/Important Bio-Agent (IBA)

1AcidsIBA
01/2017
1YH4808IBA
01/2017
1Metformin (Glucophage)FDA LinkGeneric
08/2014
1AcarboseFDA LinkGeneric
08/2014
1DexmedetomidineFDA Link
12/2012
1Probucol (Lorelco)FDA Link
11/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2011
1Clopidogrel (Plavix)FDA Link
10/2011

Therapy/Procedure

2Therapeutics
08/2014 - 10/2011